MedPath

Rubella virus vaccine

Generic Name
Rubella virus vaccine
Brand Names
M-M-R II, Proquad
Drug Type
Biotech
Unique Ingredient Identifier
52202H034Z

Overview

Rubella virus vaccine is a live attenuated virus vaccine for active immunization against rubella (German measles) that is subcutaneously administered. It is prepared from RA 27/3 strain of live attenuated rubella virus. Rubella is a common childhood disease, caused by rubella virus (togavirus).

Background

Rubella virus vaccine is a live attenuated virus vaccine for active immunization against rubella (German measles) that is subcutaneously administered. It is prepared from RA 27/3 strain of live attenuated rubella virus. Rubella is a common childhood disease, caused by rubella virus (togavirus).

Indication

Rubella virus vaccine is used to prevent rubella in combination with other virus vaccines, such as the mumps and measles virus vaccine.

Associated Conditions

  • Measles
  • Mumps
  • Rubella

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Nutritional Specialties, Inc.
83027-0071
ORAL
30 [hp_X] in 1 mL
5/15/2025
Nutritional Specialties, Inc.
83027-0070
ORAL
16 [hp_X] in 1 mL
5/15/2025
The Wellness Center for Research and Education, Inc.
50181-0042
ORAL
30 [hp_X] in 1 mL
5/28/2025

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
Authorised
5/5/2006

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
PROQUAD VACCINE
N/A
merck sharp & dohme (asia) ltd
N/A
N/A
10/5/2006
© Copyright 2025. All Rights Reserved by MedPath